At the start of this year, BC Partners, alongside Bpifrance, completed the acquisition of Biogaran – a major player in the French pharmaceutical industry and one of France’s major generic medicines companies.
Our investment in Biogaran is the perfect example of how our sector expertise and local networks combine to unlock a deal. Both our long track-record in the pharmaceutical space, and our near 40 year heritage of investing in France, were crucial in positioning us as the partner of choice and a “safe pair of hands”.
Now, with new CEO Erick Roche in place, the team are focused on finalising the carve-out of the business and investing behind its growth.
Hear from BC Partners’ Cedric Dubourdieu and Mark Hersee on why BC Partners is best positioned to deliver the next phase of growth in our latest video below.
